Light Mode
$4.11 ↓ -0.13 (-2.96%) Trading Down from the previous close of $4.23, $0.19 below the day’s high of $4.29
+0.18 (+4.44%) / 6M
Momentum, market sentiment, and recent alerts
AQST reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -34.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.